Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Clinical trial NCT02204371 · TERMINATED
Trial details
- NCT number
- NCT02204371
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-25
- Primary completion
- 2016-02-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.